The resultant cells exhibited hallmark characteristics of human CLL cells at the level of: (i) phenotype, e.g. CD19hi CD5+ CD23+ IgMlo; (ii) cell cycle phase (halted in G0/G1ex vivo); and (iii) resistance to apoptosis [32]. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.